We are live on ! Find out more
TXMD icon

TherapeuticsMD
TXMD

144 hedge funds and large institutions have $982M invested in TherapeuticsMD in 2017 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 49 increasing their positions, 34 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 20

44% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 34

13% more capital invested

Capital invested by funds: $867M → $982M (+$115M)

7% more funds holding

Funds holding: 134 → 144 (+10)

0.02% less ownership

Funds ownership: 1.52% → 1.5% (-0.02%)

63% less call options, than puts

Call options by funds: $2.71M | Put options by funds: $7.26M

Holders
144
Holders Change
+10
Holders Change %
+7.46%
% of All Funds
3.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
49
Reduced
34
Closed
20
Calls
$2.71M
Puts
$7.26M
Net Calls
-$4.55M
Net Calls Change
-$4.18M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$18.4M
2
Bank of New York Mellon
Bank of New York Mellon
New York
+$17.2M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$9.98M
4
First Eagle Investment Management
First Eagle Investment Management
New York
+$8.73M
5
AAP
Ardsley Advisory Partners
Connecticut
+$5.71M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$34.1M
2
JP Morgan Chase
JP Morgan Chase
New York
-$13.3M
3
GGHC
Gilder Gagnon Howe & Co
New York
-$12.4M
4
CCI
Columbus Circle Investors
-$10.7M
5
LCM
Laurion Capital Management
New York
-$3.49M
Name Holding Trade Value Shares
Change 		Change in
Stake
RJA
26
Raymond James & Associates
Florida
$3.14M +$729K +2,620 +34%
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
$3.04M -$2.93M -10,509 -51%
SFM
28
Sphera Funds Management
Israel
$2.9M +$557K +2,000 +26%
Goldman Sachs
29
Goldman Sachs
New York
$2.76M +$208K +746 +9%
TCM
30
Tekla Capital Management
Massachusetts
$2.54M +$2.34M +8,400 New
TCIM
31
TIAA CREF Investment Management
New York
$2.38M -$89.4K -321 -4%
1CM
32
1492 Capital Management
Wisconsin
$2.34M -$17.5K -63 -0.8%
Deutsche Bank
33
Deutsche Bank
Germany
$2.29M +$1.26M +4,513 +147%
TD Asset Management
34
TD Asset Management
Ontario, Canada
$1.97M +$168K +605 +10%
TA
35
Teachers Advisors
New York
$1.83M -$2.03M -7,296 -55%
Swiss National Bank
36
Swiss National Bank
Switzerland
$1.75M – – –
IG
37
ING Group
Netherlands
$1.63M +$5.57K +20 +0.4%
California State Teachers Retirement System (CalSTRS)
38
California State Teachers Retirement System (CalSTRS)
California
$1.58M +$62.9K +226 +5%
AllianceBernstein
39
AllianceBernstein
Tennessee
$1.54M – – –
GGHC
40
Gilder Gagnon Howe & Co
New York
$1.49M -$12.4M -44,476 -90%
New York State Common Retirement Fund
41
New York State Common Retirement Fund
New York
$1.44M – – –
Alyeska Investment Group
42
Alyeska Investment Group
Illinois
$1.4M -$1.67M -6,012 -57%
CIA
43
Capital Impact Advisors
Massachusetts
$1.21M – – –
CS
44
Candriam SCA
Luxembourg
$1.21M -$1.84M -6,600 -62%
Wells Fargo
45
Wells Fargo
California
$1.17M -$136K -487 -11%
RJFSA
46
Raymond James Financial Services Advisors
Florida
$1.06M +$186K +668 +23%
Group One Trading
47
Group One Trading
Illinois
$978K -$204K -732 -18%
CS
48
Credit Suisse
Switzerland
$937K -$55.1K -198 -6%
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$925K -$182K -654 -18%
SIP
50
Stoneridge Investment Partners
Pennsylvania
$880K – – –
1
2
3 4 5

TXMD Hedge Fund Activity: Q4 2017 in Review

144 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in TherapeuticsMD (TXMD) for Q4 2017, worth a combined $982M — up 13% from $867M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new TXMD positions and 20 closed out — a net gain of 11 holders — while 49 added to existing stakes and 34 trimmed.

The largest buyer was BlackRock, adding an estimated $18.4M. The largest seller was Fidelity Investments, cutting an estimated $34.1M.

  • 144 institutional investors held TherapeuticsMD (TXMD) as of Q4 2017, up from 134 in Q3 2017.
  • Funds reported $982M of TherapeuticsMD stock for Q4 2017, up 13% quarter-over-quarter.
  • 31 funds opened new TherapeuticsMD positions in Q4 2017 and 20 closed out, a net change of +11 holders.
  • The largest TherapeuticsMD buyer in Q4 2017 was BlackRock, an estimated $18.4M added.
  • The largest TherapeuticsMD seller in Q4 2017 was Fidelity Investments, an estimated $34.1M sold.

Based on aggregated 13F filings for Q4 2017.